MP Materials
This is the archived full research. Read the story
Owns America's only large rare-earth mine and is turning its output into the magnets inside electric motors, with the US government as guaranteed buyer and price backstop.
The scores
Growth3/4 ↑
Revenue nearly doubled on real NdPr volume (+127%), but the record is under two years and concentrated in three customers.
Business quality3/4 ↑
A real, government- and OEM-qualified position on a scarce, permitted asset, but untested by a downturn and facing an emerging domestic rival (USAR) still pre-revenue.
Financial position3/4 →
Roughly $500 million of net cash and DoW cost-sharing on 10X, but the $1.25 billion-plus buildout is not yet fully self-funded from operations alone.
Execution record3/4 ↑
6 of 8 recent EPS beats and a real FY2025 production ramp, tempered by Independence's multi-year path to first commercial magnets.
Per share capture2/4 ↓
A Preferred, Warrant and convertible notes equal to about 37% of shares outstanding sit excluded from EPS only because of the net loss.
Potential3/4 →
A large, bounded upside substantially committed via the DoW's dated, ten-year $140-million EBITDA guarantee on a facility already under construction, not merely an expected cycle.
Risk profile2/4 →
Three customers are 87% of revenue and production sits at one site - the anchor's own worked example of this score.
Valuation1/4 →
About 127.7 times operating profit before depreciation, 167% of a three-stage value near $21.20 at an 8% return: priced for perfection, beyond the 20% margin.
Evidence quality3/4 →
Central claims are primary filings and a correctly-labeled transcript, plus one independently verified government cross-check (USGS reserves); forward commitments still rest on management's own characterization.
If it works 1.3× · if it fails you keep up to 43%.
The Verdict
We rate MP Materials Unattractive. It owns America's only large rare-earth mine and is starting to make motor magnets, with the US government as guaranteed buyer, which limits the downside. But three customers are nearly all sales, the big magnet plant is not built and profit leans on a one-off sale and floor payments, so the business is mixed. The price is about 167% of our value and above our best case, assuming that plant, firm metal prices and unsigned customers. As a bet it is fragile: about a third more if it works, a little under half left if not.
The long caseGovernments want magnets made outside China, and MP runs America's only large rare-earth mine; with a price floor behind it, full magnet plants could earn well.
How we weighed it
The price against our value
Against it
Price at 167% of our value
The price sits above our value and above the bull case.
The business
Cuts both ways
Mixed
A mixed business: the government deal limits the downside, but customers are few.
Growth against what the price assumes
In its favour
Volume nearly doubled and the key customer's testing finished.
What could go wrong
Against it
Three customers are nearly everything, the plant is not built and government support can change.
Against competitors
Cuts both ways
No filed rival compares directly; against profit it is far dearer than its normal.
How its group is behaving
Cuts both ways
It sits in none of our ranked groups; critical-mineral policy moves it.
The latest news and report
Cuts both ways
The last report showed the plan working, with profit still thin.
The evidence under this - 8 claims
This mechanism only activates once 10X reaches full production capacity and sells to third parties beyond the DoW's own guaranteed purchase - years away on management's own 2028 commissioning target - so it caps a future state of the business rather than anything in today's results.
The floor guarantee that protects MP today is symmetric with a real, filed cost: once 10X is at full capacity, 30% of any NdPr price strength above $110/kg goes to the DoW rather than to shareholders.
- 2026-10-01editedRe-struck at the 2026-09-30 close ($47.29, down 11.2% from $53.20) on a pack refreshed 2026-10-01 after the thesis's 12% drift trigger fired; revenue, share count and filings are unchanged, so every multiple moved with the price alone.
- 2026-11-05editedprice re-struck at the 4 November close on Q3 revenue
MP's own 10-K risk factors warn of 'inherent risks in finalizing construction and developing the process technology for magnet manufacturing,' and Independence itself took years longer to reach commercial magnet production (first produced December 2025) than a facility of its kind might be expected to.
- 2026-11-06editedQ3 2026 call: 10X reaffirmed on schedule for late 2028; refresh_by rolled to next earnings
The company
Rare earths are the metals inside the permanent magnets that turn electric motors, from car drivetrains to robots and missiles. MP mines rare-earth ore at Mountain Pass and separates it into four products, the most valuable being NdPr, the magnet metal.
At its Independence plant in Fort Worth, Texas, it turns that metal into finished magnets. Before that plant began commercial production in December 2025, an American buyer had almost nowhere to turn but China.
The evidence under this - 1 claim
How it makes money
Most of the money still comes from selling separated rare-earth metal. When the NdPr price falls below $110 a kilogram, the government pays the difference, which brought in $59.9M in the first half. Magnets are the next leg, and the second magnet plant, 10X, comes with $140M a year of profit guaranteed by the government.
The evidence under this - 4 claims
- 2026-11-05editedQ3 2026 release replaces the Q2 figures
The floor guarantee that protects MP today is symmetric with a real, filed cost: once 10X is at full capacity, 30% of any NdPr price strength above $110/kg goes to the DoW rather than to shareholders.
- 2026-11-05editedQ3 2026 release: PPA income $8.1M, down from $17.6M
Where the money comes from, stream by stream
| Stream | Share of sales (Q2 2026) | How it earns it |
|---|---|---|
| NdPr oxide and metal | 87% | Separated neodymium-praseodymium from Mountain Pass, sold mainly through Sumitomo to Japanese buyers and under a 2026 U.S. offtake; the government tops up prices below $110/kg. |
| Magnetic precursor products | 15% | NdPr metal made at the Fort Worth Independence plant and sold to GM under its 2022 supply agreement, ahead of finished magnets. |
| Other revenue | 1% | By-products from Mountain Pass, such as lanthanum and cerium compounds. |
| Rare earth concentrate | 0% | Unseparated concentrate formerly sold to Shenghe in China; stopped in July 2025 under the DoW agreements. |
Who runs it
James Litinsky's fund bought the Mountain Pass mine in 2017 and he still runs the company; his co-founder Michael Rosenthal runs the mine, and Ryan Corbett has been finance chief since 2019. Insiders own 8.2%, mostly Litinsky's 7.2%, which he has been selling. Their bonuses and share awards ride on tonnes produced and plants started, none on profit, cash or the share price.
The evidence under this - 3 claims
Litinsky sold 885,167 shares in May and June 2026 without a plan flag (C41), so his stake is smaller than the proxy table shows.
The magnet and customer goals are confidential, so whether they were stretching cannot be checked; and output-based pay does align with the DoW milestones the price-floor and offtake economics depend on (C09, C11).
Why it wins, and who could beat it
Why customers come back
The moat is the ore. An independent consultant put Mountain Pass's reserve at 1.96 million short tons of rare-earth content, about 28 years of mining; the US Geological Survey puts the whole country's reserve at 1.9 million metric tons. A rival would need decades of permits and exploration.
So the buyers came to MP. The Department of War took a stake, Apple agreed $200.0M of prepayments, and GM named it its foundational magnet supplier.
The evidence under this - 5 claims
The magnet and recycling volumes underlying the $200.0 million are not disclosed, and the milestone conditions gating the remaining $128.0 million of prepayments are not detailed in the sources read for this thesis.
- 2026-11-05editedQ3 2026 release: GM qualification completed, deliveries from Q4
The threat
USA Rare Earth is building the only other American mine-to-magnet chain: a Texas deposit and an Oklahoma magnet line that started at about 600 tons a year in early 2026. Abroad, Lynas, the largest producer outside China, sells to the same non-Chinese buyers. Neither has the government's price floor or guaranteed purchase.
The evidence under this - 2 claims
USAR is pre-revenue at commercial scale in magnets and has no operating mine or separations facility comparable to Mountain Pass, so it is a stated strategic intent rather than a demonstrated competitor today.
The rivals: USAR, and 1 more that is private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | How far along | Priced against it |
|---|---|---|---|
| USAR | USA Rare Earth, Inc. (Nasdaq: USAR)Priced against it: Same product | On sale | Same product |
| Lynas Rare Earths Limited (ASX: LYC)Priced against it: Listed abroad | On sale | Listed abroad |
How big it could get
How big this could get
The world mined about 390,000 tons of rare-earth content in 2025, 69% of it in China; America mined 51,000, nearly all at Mountain Pass. MP produced a record 2,599 tons of NdPr last year.
A research firm MP cites sees the NdPr slice growing 8.4% a year to 2040, but that is the company's chosen source, and no independent study checks it.
The evidence under this - 4 claims
Adamas Intelligence is a third-party firm, but it is cited BY the company rather than read directly from Adamas's own publications, making this a tertiary-adjacent citation; the independently reachable government/agency source that could corroborate a magnet-specific, bottom-up demand build (the IEA's Global Critical Minerals Outlook) returned an access failure (machine.searched.prize) rather than confirming or contradicting the figure.
Who has signed
More than most. The Department of War will buy every magnet from 10X for ten years, guarantees $140M a year of profit there, and underwrites a $110 NdPr price to 2035. Apple and GM have long-term magnet agreements with prepayments but no disclosed volumes, and Sumitomo distributes its metal in Japan.
The evidence under this - 5 claims
The floor guarantee that protects MP today is symmetric with a real, filed cost: once 10X is at full capacity, 30% of any NdPr price strength above $110/kg goes to the DoW rather than to shareholders.
The magnet and recycling volumes underlying the $200.0 million are not disclosed, and the milestone conditions gating the remaining $128.0 million of prepayments are not detailed in the sources read for this thesis.
- 2026-11-05editedQ3 2026 release: GM qualification completed, deliveries from Q4
The results
The numbers
Sales grew 72% over the twelve months to Sep 2026, faster than the 10% in the year to Dec 2025.
Operating margin is −21%, down from −7.0% in the year to Dec 2023.
Yearly sales growth has ranged from −52% to +147% over the last 5 years, with sales falling in 2 of them.
Shareholders' money lost 2.0% a year, down from 14% in the year to Dec 2021.
It used $537M of cash over the last twelve months, so the $1.34B it holds lasts about 2.5 years at that pace.
It holds $1.34B of cash against $936M of debt, $402M more cash than it owes.
The share count fell 6.0% in 4.8 years, and pay in shares costs 11% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | 12 mo to Sep 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $332M | $528M | $253M | $204M | $224M | $399M |
| Sales growth | +147% | +59% | −52% | −20% | +10% | +72% |
| Profit | ||||||
| Operating margin | 50% | 62% | −7.0% | −83% | −67% | −21% |
| Net margin | 41% | 55% | 9.6% | −32% | −38% | −9.9% |
| What growth costs, per sales dollar | ||||||
| General and admin | 17% | - | - | - | - | - |
| Pay in shares | 6.9% | 6.0% | 10.0% | 11% | 13% | 11% |
| Capital spending | 37% | 62% | 103% | 91% | 77% | 121% |
| Cash | ||||||
| Cash from operations | $102M | $344M | $62.7M | $13.3M | −$156M | −$54.6M |
| Free cash flow | −$21.9M | $16.9M | −$199M | −$173M | −$328M | −$537M |
| Balance sheet | ||||||
| Cash and short-term investments | $1.18B | $1.18B | $998M | $851M | $1.83B | $1.34B |
| Debt | $675M | $678M | $682M | $909M | $999M | $936M |
| Net cash | $504M | $504M | $316M | −$57.9M | $832M | $402M |
| Returns and shares | ||||||
| Return on capital | 11% | 15% | −0.6% | - | - | - |
| Shares (diluted) | 190M | 193M | 178M | 170M | 170M | 179M |
What growth costs
Right now growth is costly. Overhead has roughly doubled while sales shrank, and in the past year the company spent more on new plants than it took in from sales, so it loses money on its sales. The latest year shows overhead's share easing as sales recover; whether it keeps easing depends on the magnet plants filling up.
The evidence under this - 2 claims
Most of the rise is a smaller revenue base, not runaway spending: revenue fell from $527.5 million in FY2022 to $224.4 million in FY2025 on NdPr prices while overhead roughly held its dollar path, and the four quarters to June 2026 already show the share falling as revenue recovered.
The last report (5 Nov)
Quarter ended September 2026, filed figures.
The third quarter of 2026 showed the ramp: sales up 176% to $147.7M, including a one-off $31.6M sale to a defence customer, and NdPr sold up 94% to 1,020 tons. MP said GM's testing of its magnets is complete, with saleable deliveries starting in the fourth quarter.
Profit is still thin. Adjusted profit before interest, tax and depreciation was $41.1M, the government's price-floor payments fell to $8.1M, magnet revenue fell 15% and the company lost $20.7M.
What it did to the thesisIt showed the plan working: the American metal sold at nearly twice the volume and the key customer's testing finished. Profit is still thin, leaning on a one-off sale and price-floor payments, and the magnet plant and customer mix are not yet proven.
The quarter in detail
Sales growth from the previous quarter, filed figures.
Earnings per share $0.04 against $-0.02 expected.
The evidence under this - 5 claims
- 2026-11-05editedQ3 2026 release replaces the Q2 figures
- 2026-11-05editedQ3 2026 release replaces the Q2 reconciliation
- 2026-11-05editedQ3 2026 release: PPA income $8.1M, down from $17.6M
- 2026-11-05editedQ3 2026 release: GM qualification completed, deliveries from Q4
What management did with the money
It holds $1.34B of cash against $0.94B of debt, after $420M of plant spending in nine months. Convertible bonds, the government's preferred stock and warrant, and staff awards could add shares equal to about 37% of those outstanding. The founder sold 2.1 million shares in the year to September, mostly without a pre-arranged plan.
Insiders in 2026Q3: 1 purchases and 0 sales, from their Form 4 filings.
The evidence under this - 3 claims
All of this dilution is currently excluded from EPS only because MP is reporting a net loss; every one of these instruments would begin diluting reported per-share results the moment MP turns a sustained GAAP profit.
- 2026-10-01editedShare price in the conversion comparison re-struck from $53.20 to $47.29 at the 2026-09-30 close; the filed figures are unchanged.
- 2026-11-05editedQ3 2026 release balance sheet
- An absent 10b5-1 flag is not proof of discretion, only the absence of a claimed defence; the filings show intent was not pre-scheduled, not why he sold.
- His last Form 4 in the window leaves him holding 11,794,225 shares directly, so the selling trims a very large holding rather than exiting it; and the COO's two purchases, both near today's price, point the other way on a much smaller scale.
The price, and where we disagree
In short. Priced for perfection. The price is about 167% of what we think the business is worth, at an 8% yearly return.
The shares are about 64% below their high, after falling about 24% since the end of September, while the business has two dated tests. GM's saleable magnet deliveries are due to begin in the fourth quarter of 2026, and 10X is due to begin commissioning in 2028. The first read of GM's deliveries comes with the December-quarter results in February 2027.
The evidence under this - 3 claims
- 2026-10-01editedRe-struck at the 2026-09-30 close from the 2026-10-01 pack after the 12% drift trigger fired: the close fell from $53.20 to $47.29 and the volatility bucket moved from Volatile to Stable.
- 2026-11-05editedprice re-struck at the 4 November close
Regular commercial magnet deliveries to GM have already been delayed for years relative to when the Independence Facility and the GM agreement were first announced (agreement dated April 2022; magnet manufacturing only began commissioning in late 2025), so a Q4 2026 target carries the same execution risk that has already slipped once.
- 2026-11-05editedQ3 2026 release matches the call's timeline
MP's own 10-K risk factors warn of 'inherent risks in finalizing construction and developing the process technology for magnet manufacturing,' and Independence itself took years longer to reach commercial magnet production (first produced December 2025) than a facility of its kind might be expected to.
- 2026-11-06editedQ3 2026 call: 10X reaffirmed on schedule for late 2028; refresh_by rolled to next earnings
How we value it
- Method
- Cash the business will produce, with any shortfall raised in new shares
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- An average moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 30%, 17.9%, 10% | 60%, 35.8%, 20% | 75%, 44.8%, 25% |
| Normal operating margin | 26.8% | 33.5% | 36.8% |
| Return on new capital after year ten | 8% | 12% | 15% |
| Value a share | $8.17 | $21.20 | $31.62 |
- Price
- $35.41
- Priced on
- 6 Nov
- Price as a share of the base value
- 167%
- Yearly return the price offers on the base case
- 6.6%
- Risk check: valued at 12%, the rate for a business not yet making a profit
- $8.62
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last twelve months | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Operating margin today | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Tax rate | Our method's rule | The normal rate where no rate is filed to read: 25% for a US company, 21% elsewhere. |
| Sales per dollar of new capital | Our judgement | Our reading of the evidence. |
| Shares | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 31 Dec 2026, 31 Dec 2027 and 31 Dec 2028, as it stood when the value was struck on 10 Nov 2026: the average of 5 to 10 analysts' revenue estimates, 60%, 35.8%, 20%, each year held to at most 60%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 31 Dec 2028, as it stood when the value was struck on 10 Nov 2026, the average of 10 analysts' estimates, less stock pay and less the 3% the analysts add back on their adjusted basis: 33.5% in the base case. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 6 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, 30%, 18% and 10%, the margin settles a fifth lower at 26.8%, and new capital earns only the 8% rate: the downturn test.
Base caseRevenue grows 60%, 36% and 20% over three years, the analysts' path (C51), held to at most 60% a year, then fades toward 4%, closing 30% of the gap each year; the margin moves to 33.5%, the analysts' year-three figure after stock pay and on the filed basis (3.0% less), with stock pay, today 11.3% of sales, at a mature 6%.
Bull caseGrowth runs a quarter above the analysts' path, 75%, 45% and 25%, the margin reaches 36.8%, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $17.21 | $25.56 |
| The normal margin, 15% lower or higher | $17.51 | $24.97 |
| Capital per dollar of growth, a quarter more or less | $19.07 | $22.66 |
| Return on new capital after year ten, at the rate or one step up | $15.81 | $23.36 |
| The rate, a point higher or lower | $16.07 | $29.88 |
| Long-run growth a point lower | $18.79 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 26.8% | $10.68 | $13.32 | $16.32 | $19.57 | $22.97 |
| 30.2% | $12.17 | $15.25 | $18.73 | $22.53 | $26.52 |
| 33.5% | $13.70 | $17.21 | $21.20 | $25.56 | $30.18 |
| 36.9% | $15.25 | $19.19 | $23.70 | $28.66 | $33.96 |
| 40.2% | $16.80 | $21.19 | $26.24 | $31.80 | $37.80 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
The shares alone cost $6.40B, for roughly $400M of yearly sales: about 16 times sales, close to MP's own usual 16.5. Against profit the price is still far above its usual level.
For that price to make sense:
- The 10X magnet plant must open on time, in 2028.
- NdPr, the magnet metal MP mines, must stay at or above the $110 a kilogram the government guarantees.
- New customers must sign.
- Even then, once 10X runs full, the government keeps 30% of any price above $110, and part of 10X's profit.
Against its own history. Near its own usual level against sales after the fall, but far dearer against profit, for a plant that does not yet exist.
The evidence under this - 4 claims
- 2026-10-01editedRe-struck at the 2026-09-30 close ($47.29, down 11.2% from $53.20) on a pack refreshed 2026-10-01 after the thesis's 12% drift trigger fired; revenue, share count and filings are unchanged, so every multiple moved with the price alone.
- 2026-11-05editedprice re-struck at the 4 November close on Q3 revenue
Even if 10X and Independence both deliver as guided and NdPr holds above $110/kg, the DoW's own PPA and Offtake terms (C10, C11) claim a real share of the resulting upside, so the price is not simply buying 100% of the good outcome it appears to assume.
- 2026-10-01editedMarket cap re-struck from $9.48 billion to $8.42 billion at the 2026-09-30 close; the revenue and Adjusted EBITDA figures and the delivery conditions it names are unchanged.
- 2026-11-05editedprice and Q3 earnings power re-struck
The floor guarantee that protects MP today is symmetric with a real, filed cost: once 10X is at full capacity, 30% of any NdPr price strength above $110/kg goes to the DoW rather than to shareholders.
This mechanism only activates once 10X reaches full production capacity and sells to third parties beyond the DoW's own guaranteed purchase - years away on management's own 2028 commissioning target - so it caps a future state of the business rather than anything in today's results.
Priced against its rivals
Only USA Rare Earth sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.
Private or foreign rivals that cannot be priced: Lynas Rare Earths Limited, China Northern Rare Earth Group / China Rare Earth Group.
The bet: what it pays if it works
This is a bet on two magnet plants filling up under a government guarantee. Even if both run full within three years and earn what the guarantee implies per tonne, the business would be worth only a little more than today's value, even priced generously. As a bet, the shares look expensive.
If it fails, shareholders keep a mine with a government price floor and some net cash, but the government's preferred shares rank ahead and conversions would add over a third more shares.
| EBITDA in two to three years | Tonnes of magnets a year needed | At the stated multiple |
|---|---|---|
| $226.00M | about 7.0K at 100% kept | 1.0× |
| $286.00M (the big win) | about 10.0K at 100% kept | 1.3× |
To pay 2× (a Fair bet) it would need about $445.10M of EBITDA (about 18.0K tonnes of magnets a year); to pay 5× (a Cheap bet), about $1.11B of EBITDA (about 51.3K tonnes of magnets a year), at the same multiple.
The steps it has to take
- Done Government equity, magnet offtake and NdPr price-floor agreements signed
- Done Price floor paying: $59.9M of income in the first half of 2026
- Done Apple magnet supply agreement signed, $72M of $200M prepayments received
- Done Land for 10X closed and construction under way
- In progress Q3 2026 print: GM qualification on track and the new offtake customer visible in the concentration table due 2026-11-05
- In progress GM's regular commercial magnet deliveries begin due 2026-12
- In progress Ore-sorting facility at full design capacity due 2027-03
- Not started Apple magnet revenue begins due 2027-12
- In progress 10X begins commissioning due 2028-12
- Not started Revenue spread beyond three customers as 10X output ramps due 2028-12
- Not started 10X earning at least the $140M guaranteed EBITDA a year due 2029-09
The detail behind the label
The evidence under this - 6 claims
MP's own 10-K risk factors warn of 'inherent risks in finalizing construction and developing the process technology for magnet manufacturing,' and Independence itself took years longer to reach commercial magnet production (first produced December 2025) than a facility of its kind might be expected to.
- 2026-11-06editedQ3 2026 call: 10X reaffirmed on schedule for late 2028; refresh_by rolled to next earnings
This mechanism only activates once 10X reaches full production capacity and sells to third parties beyond the DoW's own guaranteed purchase - years away on management's own 2028 commissioning target - so it caps a future state of the business rather than anything in today's results.
The floor guarantee that protects MP today is symmetric with a real, filed cost: once 10X is at full capacity, 30% of any NdPr price strength above $110/kg goes to the DoW rather than to shareholders.
All of this dilution is currently excluded from EPS only because MP is reporting a net loss; every one of these instruments would begin diluting reported per-share results the moment MP turns a sustained GAAP profit.
- 2026-10-01editedShare price in the conversion comparison re-struck from $53.20 to $47.29 at the 2026-09-30 close; the filed figures are unchanged.
- 2026-11-05editedQ3 2026 release balance sheet
Where we disagree with the market
A rare-earths winner whose price rises with every government and customer deal: 13 of 14 analysts say buy.
The government ties cut demand risk more than the price shows, but the same contracts already claim part of the upside.
The upside-sharing sits in the notes to the filings, not the headlines: 30% of any NdPr price above $110 once 10X is at full capacity, and a first claim on 10X's profit above its guarantee.
We are wrong if NdPr holds above $110 once 10X ramps, the government lets MP sell surplus magnets to others instead of claiming them, and new customers sign before 10X reports.
What analysts say, and the evidence
The evidence under this - 5 claims
- 2026-10-01editedRe-read on the 2026-10-01 pack: the snapshot is unchanged at 13 buy, 1 hold, 0 sell, and the dated series shows 94.7% positive on 19 analysts, the same as a month earlier.
This mechanism only activates once 10X reaches full production capacity and sells to third parties beyond the DoW's own guaranteed purchase - years away on management's own 2028 commissioning target - so it caps a future state of the business rather than anything in today's results.
The floor guarantee that protects MP today is symmetric with a real, filed cost: once 10X is at full capacity, 30% of any NdPr price strength above $110/kg goes to the DoW rather than to shareholders.
- 2026-11-05editedQ3 2026 release replaces the Q2 reconciliation
- 2026-10-01editedRe-struck at the 2026-09-30 close ($47.29, down 11.2% from $53.20) on a pack refreshed 2026-10-01 after the thesis's 12% drift trigger fired; revenue, share count and filings are unchanged, so every multiple moved with the price alone.
- 2026-11-05editedprice re-struck at the 4 November close on Q3 revenue
What could go wrong, and how we would know
The risks
- Three customers, nearly everything. Three unnamed customers were about 87% of June-quarter sales, and a year earlier the list was different.
- A plant not yet built. 10X needs more than $1.25B and is due to start commissioning in 2028; any slip delays the guaranteed profit.
- Government support can change. The price floor and the purchase promise depend on continued funding and political backing.
- Heavy short selling. 23.3% of the shares available to trade were sold short at the mid-September count, up from 20.2% in August.
The evidence under this - 6 claims
- 2026-11-06editedQ3 2026 10-Q filed 2026-11-06: largest customer down to 33% from 40%, but four customers now hold 89%
MP's own 10-K risk factors warn of 'inherent risks in finalizing construction and developing the process technology for magnet manufacturing,' and Independence itself took years longer to reach commercial magnet production (first produced December 2025) than a facility of its kind might be expected to.
- 2026-11-06editedQ3 2026 call: 10X reaffirmed on schedule for late 2028; refresh_by rolled to next earnings
The floor guarantee that protects MP today is symmetric with a real, filed cost: once 10X is at full capacity, 30% of any NdPr price strength above $110/kg goes to the DoW rather than to shareholders.
- 2026-10-01editedRefresh trigger reached: FINRA's 2026-08-31 and 2026-09-15 settlements are out. Short interest rose from 29.2 million shares (20.2% of float) to 33.6 million (23.3%).
What we still do not know
- Who the largest customers are; the filings name none. The Q3 report shows four customers at 89% of sales, the biggest at 33%, down from 40%.
- Whether the $31.6M defence sale is the nine-figure gadolinium deal management described, or a one-off.
- How much GM will buy in the first quarter of saleable deliveries.
The evidence under this - 3 claims
- 2026-11-06editedQ3 2026 10-Q filed 2026-11-06: largest customer down to 33% from 40%, but four customers now hold 89%
Regular commercial magnet deliveries to GM have already been delayed for years relative to when the Independence Facility and the GM agreement were first announced (agreement dated April 2022; magnet manufacturing only began commissioning in late 2025), so a Q4 2026 target carries the same execution risk that has already slipped once.
- 2026-11-05editedQ3 2026 release matches the call's timeline
No dollar figure, volume or specific term is disclosed beyond 'nine figures over time,' and the counterparty is not named anywhere in the call, the release, or the 10-Q.
What would change our view
- Unattractive→NeutralThe price falls back within 20% of fair value
It needs:
- ○The share price falls to about $25.44, back within 20% of what we think the business is worth.about ≈$24.76 today, 48% below the last close
- Unattractive→AttractiveThe price falls 20% under fair value
It needs:
- ○The share price falls to about $16.96, 80% of what we think the business is worth.about ≈$15.69 today, 67% below the last close
- Unattractive→AttractiveThe plant and the customers both arrive
It needs all of:
- ○10X stays on track to start in 2028, and GM's regular magnet deliveries begin as planned.watched as it happens
- ○Sales spread beyond today's three or four big buyers as 10X output ramps.checked at the next results, due by 26 Feb
We would also be wrong if
- GM's regular magnet deliveries do not start in the fourth quarter of 2026.
What is coming
- 5 November 2026 Q3 2026 results: Whether GM magnet deliveries are still set for the fourth quarter, whether revenue holds its growth, and how much the price floor paid.
Every dated event ahead
- 5 November 2026 Q3 2026 results: Whether GM magnet deliveries are still set for the fourth quarter, whether revenue holds its growth, and how much the price floor paid.
- December 2026 First heavy rare earth output (terbium, dysprosium): Whether the heavy rare earth circuit the DoW deal and the special pay awards hinge on starts on time, or slips like Independence did.
- December 2026 Regular magnet deliveries to GM begin: Whether Independence is a magnet plant with a paying customer rather than a precursor-metal plant; another slip would test the 10X timeline.
- February 2027 Q4 2026 results and the FY2026 10-K: A full year under the price floor and without China sales: revenue mix, the cost of overhead per sales dollar, and the 10X spending plan.
- March 2027 Ore sorting facility at full design capacity: Whether lower-grade ore becomes usable feed, which bears on Mountain Pass supplying both magnet plants.
Since we wrote this
- 9 NovThesis reviewUnattractive: priced at 156% of a value near $22.74Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits beyond the 20% margin of safety.
- 6 NovEarningsCall and 10-Q: 10X on schedule, top customer down to 33%Management reaffirmed 10X for late 2028 and the largest customer fell from 40% to 33%, but four customers still hold 89% and magnet profit stays modest into 2027.
- 5 NovEarningsGM qualification complete; view holds at NeutralGM's testing finished on time and a defence customer appeared, but the plant and customer mix remain unproven and profit is thin.
- 1 NovThesis reviewA binding Saudi refinery venture with Maaden and the Department of WarA November 2025 filing we had not read: a Saudi refinery venture, binding but with no size or date. The view is unchanged.
- 5 OctThesis reviewThe bet now names what it ridesThe owner asked that every bet name the macro trend behind it, after BWXT's bet was missing its chief executive's case for nuclear over gas.
- 4 OctThesis reviewOwner's checklist: revenue streams, cost of growth, management, catalystsThe owner's checklist found the method silent on who runs the company, what growth costs, where the money comes from and what is dated ahead; this pass fills those four blocks from the proxy and filings.
- 1 OctPrice moveShares fell 11% to $47.29; the case is unchanged. View heldNo news or filing moved the plant schedule or the customers. At 27.6 times sales against a usual 16.5 the price still assumes most of the good outcome, and short selling rose to 23.3% of shares.
- 26 SepThesis reviewFounder sold 2.1 million shares in the year, not 242,000The thesis had counted six of the chairman's 25 sales. Over the year he sold 2,118,578 shares at $63 to $71, most without a pre-arranged plan. The view held: it rests on the magnet build-out, not his selling.
- 1 SepThesis writtenNeutral, medium convictionWritten a month after June-quarter results, with volumes climbing fast and the shares 46.9% below their high.
Also checked 4 times with nothing new to act on.
Sources 22
Sources - 22
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-02-26business description, segments, DoW Transaction Agreements mechanics (including the DoW upside-sharing terms), SRK reserve/resource estimate, competition section, Apple/GM/Sumitomo agreement descriptionsbacksC01C02C04C05C06C07C09C10C13C15C16C40C43C44C46C47
- S02primarycompany filing2026-08-07Q2 2026 results, customer concentration table, PPA/Offtake note detail, capital structure and dilutive-instrument detail, Apple/GM deferred-revenue detailbacksC08C09C11C12C14C15C17C21C22C28C31C42C43C47C48
- S03primarycompany filing2026-02-26FY2025 full-year and Q4 2025 results, segment financials, FY2025 production/sales highlights, DoW/Apple partnership announcementsbacksC13C20C28C38
- S04primarycompany filing2026-08-06Q2 2026 headline results, the new aerospace/defense gadolinium offtake announcement, Project Swarm announcementread, but no claim rests on it
- S05primarygovernment data2026independent US and world rare-earth mine production and reserve figures, and net import reliance data, none of it sourced to the company
Bastnaesite was mined as a primary product in Mountain Pass, CA. An estimated 51,000 tons of REO in mineral concentrates was produced and was valued at $240 million. World Mine Production and Reserves table: United States 45,500 (2024) 51,000 (2025) 1,900,000 (reserves); China 270,000 (2024) 270,000 (2025) 44,000,000 (reserves); World total (rounded) 380,000 (2024) 390,000 (2025). Net import reliance as a percentage of apparent consumption, compounds and metals: >95 (2021) >95 (2022) >90 (2023) 53 (2024) 67 (2025).
backsC03C06C37 - S06secondaryvendor data2026-09-01Portfolio-management research pack (vendor_fundamentals tier: annual revenue series)content/MP/research-pack.jsonannual revenue history FY2021-FY2025backsC20
- S07primarycompany filing2026-03-30an outside, product-matched competitor's own description of the same integrated mine-to-magnet strategy, its Stillwater magnet facility status, and its scale relative to MPbacksC23
- S08secondaryindustry data2026a qualitative description of Lynas's operations and market position; no verbatim primary quote from Lynas's own results could be frozen (machine.searched.threat notes the access failure), so no specific production/capacity figure from Lynas is cited as a claim
Lynas Rare Earths is the largest rare-earth producer outside China.
backsC24 - S09secondaryvendor data2026-09-01Portfolio-management research pack (market tier: insider Form 4 transactions)content/MP/research-pack.jsoninsider transaction detail (already filtered to open-market purchases/sales by transaction code, per research-protocol.md)backsC25C41
- S10primarygovernment data2026-08-14FINRA Consolidated Short Interest (via research pack)content/MP/research-pack.jsonshort interest, percent of float, days to cover, settled 2026-08-14backsC26
- S11secondaryvendor data2026-09-01Portfolio-management research pack (market tier: price, valuation, analyst consensus, technicals)content/MP/research-pack.jsoncurrent price/returns/volatility, TTM valuation multiples against own-history medians, analyst consensus, earnings historybacksC27C28C29C31
- S12primarytranscript2026-08-06MP Materials Q2 2026 earnings call transcript (question section)Alpha Vantage EARNINGS_CALL_TRANSCRIPT, ticker=MP, quarter=2026Q2management's answers on the new gadolinium offtake, 10X demand/allocation, GM qualification timeline, NdPr-as-binding-constraint framing, and the reagent supply-chain shift; same independence group as S04 (same management, same day)backsC32C33C34C35C36
- S13primarycompany filing2026-05-07confirmation that MP broke ground on the 10X Facility in Q1 2026, plus Q1 2026 segment detail consistent with the ramp described in later quartersbacksC22C31
- S14primarycompany filing2026-06-05the Rule 10b5-1 flag on each of the chief executive's 25 open-market sales, which the vendor feed does not carry: four (600,000 shares, January and April 2026) marked as under a plan, 21 unmarkedbacksC41
- S15primarycompany filing2026-04-24beneficial ownership as of April 13, 2026, the executive officers' backgrounds and start dates, the 2025 annual incentive plan and its goals, the 2025 and October 2025 performance share grants, related-person transactionsbacksC44C45C46C47
- S16primarycompany filing2023-02-28the FY2021 and FY2022 income statements: revenue, selling, general and administrative, and the advanced projects linebacksC43
- S17primarycompany filing2025-11-19the binding three-party agreement, the 49% / 51% split, non-recourse DoW financing of the US share, MP's contributionbacksC49
- S18primarycompany filing2026-11-05Q3 revenue, NdPr volumes, segment EBITDA, price protection income, balance sheet, GM qualification milestonebacksC12C15C18C19C21C35C50
- S19primarytranscript2026-11-0510X on schedule for late 2028, Q4 outlook, magnet ramp pace, SEG+ sale context, analyst questionsbacksC22
- S20primarycompany filing2026-11-06Q3 customer concentration tablebacksC17
- S21primarycompany filing2026-11-09trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share countbacksC52
- S22secondaryvendor data2026-11-09the analysts' average revenue and operating profit for the next three fiscal years, and the closebacksC51C52